To assess the predictive potential of a model based on DNA methylation biomarkers for lung cancer risk among both ever and never smokers.
Approach:
Key Findings:
The model demonstrated the ability to predict both short-term and long-term lung cancer risk.
The study included both ever and never smokers, addressing a gap in current screening guidelines.
Interpretation:
The findings suggest that DNA methylation biomarkers can enhance lung cancer risk prediction, potentially including never smokers in screening strategies.
Limitations:
The study's applicability may be limited to the populations studied in Germany and Norway.
The model's performance in diverse populations and settings remains to be evaluated.
Conclusion:
The study highlights the potential of DNA methylation biomarkers in predicting lung cancer risk, which could inform future screening practices.
